Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.
about
Immunotherapy for head and neck squamous cell carcinomahrHPV E5 oncoprotein: immune evasion and related immunotherapies.Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma.Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells.Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.Progress and opportunities for immune therapeutics in osteosarcoma.Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy.Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway.Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells.Immune recognition of irradiated cancer cells.A correlative analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 expression in oropharyngeal squamous cell carcinoma.T-Cell Epitope Discovery for Therapeutic Cancer Vaccines.[Immunotherapy of head and neck tumors: Highlights of the ASCO Meeting 2015].Combination nivolumab with transcatheter arterial chemoembolization for clinical remission of small cell lung cancer: A case report.Checkpoint immunotherapy in head and neck cancers.Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
P2860
Q26739850-D31C2721-FBB3-4409-BE73-954A6F1762CBQ33730462-45682E48-3270-41F5-8121-38F876B10315Q35927872-DBE04CAF-9C24-4696-85F5-6B718AA05195Q36401731-31CF13BA-773E-43CA-B1E4-416A6FC4ABFBQ36561681-CD63B332-E46F-493B-9DF7-2F65DCD2D8D5Q36666694-7C1D68DC-F04D-439D-BE21-A68E999AE986Q37100703-B07BC47A-E1AA-46F0-A03E-5D671C01512EQ37525422-6ED1272E-F3F5-4A7A-BADB-380AFA522783Q37705029-6867C4FF-5BCB-44E3-98BD-1AE1EB1EAC9CQ38948905-6788655F-26AF-413D-B9DB-CCA4B096C0A0Q41633683-26374DA0-5124-45F3-8722-7A48D7AF275AQ44243898-5F416638-7464-498C-9B6A-0161FC07EA8FQ47435134-E23B7503-5A7A-4EC1-B0DC-0E810AF8D968Q48193633-B8EF9B7D-5EC2-4AB4-9B93-870C903A4100Q50027076-950EAA19-A3C6-41AF-8B0A-4427DE65A768Q50861629-5013EC17-4A41-4504-8F26-062C36DCDF88Q51287462-3C4BF635-7BED-4417-AA75-DD84414E5E55Q52677629-D92B045C-834D-4D06-AE49-33EB750A58C9Q53098427-246C1DBE-96AA-4F37-8725-A12F94536347Q58119192-CF74DE4F-48FD-47A5-805B-7A1A42A379F6
P2860
Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Chemoradiotherapy-induced upre ...... -related oropharyngeal cancer.
@ast
Chemoradiotherapy-induced upre ...... -related oropharyngeal cancer.
@en
type
label
Chemoradiotherapy-induced upre ...... -related oropharyngeal cancer.
@ast
Chemoradiotherapy-induced upre ...... -related oropharyngeal cancer.
@en
prefLabel
Chemoradiotherapy-induced upre ...... -related oropharyngeal cancer.
@ast
Chemoradiotherapy-induced upre ...... -related oropharyngeal cancer.
@en
P2093
P2860
P1433
P1476
Chemoradiotherapy-induced upre ...... -related oropharyngeal cancer.
@en
P2093
Alexis Patsias
Amelia Clark
Andrew G Sikora
David Y Zhang
Dorothée Duluc
Elizabeth G Demicco
Falguni Parikh
Johnny Kao
Krzys Misiukiewicz
Marcello Bonomi
P2860
P304
P356
10.1158/0008-5472.CAN-14-1913
P407
P577
2014-10-15T00:00:00Z